Literature DB >> 2390097

A monoclonal antibody directed to Tn antigen.

Y Numata1, H Nakada, S Fukui, H Kitagawa, K Ozaki, M Inoue, T Kawasaki, I Funakoshi, I Yamashina.   

Abstract

A murine monoclonal antibody, MLS 128, that was assigned to an anti-Tn antibody has been established by immunizing mice with human colonic cancer cells (LS 180). MLS 128 bound to mucin glycopeptides from LS 180 cells and their asialo forms to the same extent as well as to ovine submaxillary mucin (OSM) and asialo OSM. Special non-sialylated GalNAc residue(s) attached to a certain peptide region in the antigens seems to be involved in the binding since N-acetylgalactosaminidase treatment of the antigen abolished the binding and pronase digestion diminished the binding markedly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390097     DOI: 10.1016/0006-291x(90)90488-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Authors:  Ola Blixt; Olga I Lavrova; Dmitriy V Mazurov; Emiliano Cló; Stjepan K Kracun; Nicolai V Bovin; Alexander V Filatov
Journal:  Glycobiology       Date:  2011-12-05       Impact factor: 4.313

2.  Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.

Authors:  Yasuyuki Matsumoto; Matthew R Kudelka; Melinda S Hanes; Sylvain Lehoux; Sucharita Dutta; Mark B Jones; Kathryn A Stackhouse; Gabrielle E Cervoni; Jamie Heimburg-Molinaro; David F Smith; Tongzhong Ju; Elliot L Chaikof; Richard D Cummings
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

3.  Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract.

Authors:  G Ohshio; T Imamura; M Imamura; H Yamabe; H Sakahara; H Nakada; I Yamashina
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Novel glycoproteins inhibiting the binding of colorectal cancer cells to E-selectin.

Authors:  M Inoue; H Nakada; Y Oka; N Tanaka; I Yamashina
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

5.  Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).

Authors:  H Nakada; M Inoue; Y Numata; N Tanaka; I Funakoshi; S Fukui; A Mellors; I Yamashina
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

7.  Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn.

Authors:  H Nakada; M Inoue; N Tanaka; I Yamashina
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

8.  Trimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin α5β1 and matrix metalloproteinase 9.

Authors:  Yasuyuki Matsumoto; Qing Zhang; Kaoru Akita; Hiroshi Nakada; Kazunori Hamamura; Akiko Tsuchida; Tetsuya Okajima; Keiko Furukawa; Takeshi Urano; Koichi Furukawa
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

Review 9.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

10.  A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.

Authors:  Carla Danussi; Anna Coslovi; Cristiana Campa; Maria T Mucignat; Paola Spessotto; Fulvio Uggeri; Sergio Paoletti; Alfonso Colombatti
Journal:  Glycobiology       Date:  2009-06-15       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.